Literature DB >> 25575295

A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale.

Matthew P Myrvik1, Amy L Drendel, Amanda M Brandow, Ke Yan, Raymond G Hoffmann, Julie A Panepinto.   

Abstract

Given the availability of various pain severity scales, greater understanding of the agreement between pain scales is warranted. We compared Visual Analog Scale (VAS) and Numeric Rating Scale (NRS) pain severity ratings in children with sickle cell disease (SCD) to identify the relationship and agreement between pain scale ratings. Twenty-eight patients (mean ± SD age, 14.65 ± 3.12 y, 50% female) receiving pain interventions within the emergency department completed serial VAS and NRS pain severity ratings every 30 minutes. Data were used to calculate the relationship (Spearman correlation) and agreement (Bland-Altman approach) between the VAS and NRS. One hundred twenty-eight paired VAS-NRS measurements were obtained. VAS and NRS ratings were significantly correlated for the initial assessment (rs = 0.88, P < 0.001) and all assessments (rs = 0.87, P < 0.001). Differences between VAS and NRS means were -0.52 (P = 0.006) for the initial assessment and -0.86 (P < 0.001) across all assessments. The difference between VAS and NRS ratings decreased as pain severity increased across all assessments (P = 0.027), but not the initial assessment. Within pediatric patients with SCD, VAS and NRS ratings were found to trend together; however, VAS scores were found to be significantly lower than NRS scores across assessments. The agreement between the 2 measures improved at increasing levels of pain severity. These findings demonstrate that the VAS and NRS are similar, but cannot be used interchangeably when assessing self-reported pain in SCD.

Entities:  

Mesh:

Year:  2015        PMID: 25575295     DOI: 10.1097/MPH.0000000000000306

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  What is the future of patient-reported outcomes in sickle-cell disease?

Authors:  Sharon A Singh; Nitya Bakshi; Prashant Mahajan; Claudia R Morris
Journal:  Expert Rev Hematol       Date:  2020-10-15       Impact factor: 2.929

2.  Validity and Reliability of the Verbal Numerical Rating Scale for Children Aged 4 to 17 Years With Acute Pain.

Authors:  Daniel S Tsze; Carl L von Baeyer; Vartan Pahalyants; Peter S Dayan
Journal:  Ann Emerg Med       Date:  2017-11-06       Impact factor: 5.721

3.  Comparison of the effects of ketamine and fentanyl-midazolam-medetomidine for sedation of rhesus macaques (Macaca mulatta).

Authors:  Henri G M J Bertrand; Yvette C Ellen; Stevie O'Keefe; Paul A Flecknell
Journal:  BMC Vet Res       Date:  2016-06-08       Impact factor: 2.741

4.  Recruitment and inclusion procedures as "pain killers" in clinical trials?

Authors:  H Nothnagel; M Brown Menard; G Kvarstein; A J Norheim; T Weiss; C Puta; S D Mist; F Musial
Journal:  J Pain Res       Date:  2019-07-03       Impact factor: 3.133

5.  Infrapatellar versus suprapatellar approach for intramedullary nailing of the tibia: a systematic review and meta-analysis.

Authors:  Nikhil Ponugoti; Branavan Rudran; Amr Selim; Sam Nahas; Henry Magill
Journal:  J Orthop Surg Res       Date:  2021-01-28       Impact factor: 2.359

6.  Physicians' use of pain scale and treatment procedures among children and youth in emergency primary care - a cross sectional study.

Authors:  Svein-Denis Moutte; Christina Brudvik; Tone Morken
Journal:  BMC Emerg Med       Date:  2015-11-06

7.  Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy.

Authors:  YunLong Zhang; Yongpei Li; Hongfa Wang; Fang Cai; Sheliang Shen; Xiaopan Luo
Journal:  Oncotarget       Date:  2017-12-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.